Abstract:Background: Carotid-femoral pulse wave velocity (cfPWV), acknowledged as a reliable proxy of arterial stiffness, is an independent predictor of cardiovascular (CV) events. Carotid-femoral PWV is considered the gold standard for the estimation of arterial stiffness. cfPWV is a demanding, time consuming and expensive method, and an estimated PWV (ePWV) has been suggested as an alternative method when cfPWV is not available. Our aim was to analyze the predictive role of ePWV for CV and all-cause mortality in the general population. Methods: In a stratified random sample of 1086 subjects from the general Croatian adult population (EH-UH study) (men 42.4%, average age 53 ± 16), subjects were followed for 17 years. ePWV was calculated using the following formula: ePWV = 9.587 − 0.402 × age + 4.560 × 10−3 × age2 − 2.621 × 10−5 × age2 × MBP + 3.176 × 10−3 × age × MBP − 1.832 × 10−2 × MBP. MBP= (DBP) + 0.4(SBP − DBP). Results: At the end of the follow-up period, there were 228 deaths (CV, stroke, cancer, dementia and degenerative diseases, COLD, and others 43.4%, 10.5%, 28.5%, 5.2%, 3.1%, 9.3%, respectively). In the third ePWV tercile, we observed more deaths due to CV disease than to cancer (20.5% vs. 51.04%). In a Cox regression analysis, for each increase in ePWV of 1 m/s, there was a 14% increase risk for CV death. In the subgroup of subjects with higher CV risk, we found ePWV to be a significant predictor of CV deaths (ePWV (m/s) CI 1.108; p < 0.029; HR 3.03, 95% CI 1.118–8.211). Conclusions: In subjects with high CV risk, ePWV was a significant and independent predictor of CV mortality.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to evaluate the role of estimated pulse wave velocity (ePWV) in predicting cardiovascular (CV) mortality and all - cause mortality in the general population. Specifically, the study aims to explore whether ePWV calculated based on age and mean blood pressure (MBP) can be used as an effective indicator of cardiovascular health in the absence of direct measurement of carotid - femoral artery pulse wave velocity (cfPWV), and whether it can predict cardiovascular mortality and all - cause mortality independently of traditional cardiovascular risk factors. ### Research Background Arterial stiffness is an important biomarker of cardiovascular health and can be directly and non - invasively measured by carotid - femoral artery pulse wave velocity (cfPWV). cfPWV is considered the gold - standard method for assessing arterial stiffness, but its operation is complex, time - consuming and costly, so it is less used in clinical practice. To overcome these limitations, researchers have proposed an estimated pulse wave velocity (ePWV) calculation method based on age and mean blood pressure (MBP) to replace cfPWV. ### Research Objectives The main objective of this study is to analyze the role of ePWV in predicting cardiovascular (CV) mortality and all - cause mortality in the general population. Specifically, the research team hopes to verify whether ePWV can be an effective indicator of cardiovascular health in the absence of cfPWV and predict cardiovascular mortality and all - cause mortality independently of traditional cardiovascular risk factors. ### Methods - **Research Subjects**: The research subjects were from a stratified random sample of the Croatian national adult population (EH - UH study), with a total of 1,086 participants (42.4% male, mean age 53 ± 16 years). - **Follow - up Time**: The participants were followed up for 17 years. - **ePWV Calculation**: ePWV is calculated by the following formula: \[ \text{ePWV} = 9.587 - 0.402\times\text{age}+4.560\times 10^{- 3}\times\text{age}^2-2.621\times 10^{-5}\times\text{age}^2\times\text{MBP}+3.176\times 10^{-3}\times\text{age}\times\text{MBP}-1.832\times 10^{-2}\times\text{MBP} \] where \(\text{MBP}=\text{diastolic blood pressure}+0.4\times(\text{systolic blood pressure}-\text{diastolic blood pressure})\). ### Results - **Death Events**: During the follow - up period, a total of 228 people died, of which 43.4% died of cardiovascular diseases, 10.5% died of stroke, 28.5% died of cancer, 5.2% died of dementia, 3.1% died of degenerative diseases, and 9.3% died of other causes. - **Relationship between ePWV and Mortality**: In the third ePWV tertile, the proportion of cardiovascular disease deaths was higher than that of cancer deaths (20.5% vs. 51.04%). Cox regression analysis showed that for every 1 m/s increase in ePWV, the risk of cardiovascular death increased by 14%. In the subgroup with high cardiovascular risk, ePWV was a significant predictor of cardiovascular death (ePWV (m/s) CI 1.108; p < 0.029; HR 3.03, 95% CI 1.118 - 8.211). ### Conclusions In individuals with high cardiovascular risk, ePWV is a significant and independent predictor of cardiovascular mortality. This indicates that ePWV may be used as a simple and effective tool in clinical practice to assess the risk of cardiovascular and non - cardiovascular death in the general population.

Estimated Pulse Wave Velocity and All-Cause and Cardiovascular Mortality in the General Population

Estimated pulse wave velocity is associated with all-cause and cardio-cerebrovascular disease mortality in stroke population: Results from NHANES (2003–2014)

Estimated Pulse Wave Velocity Predicts All-Cause and Cardiovascular-Cause Mortality in Individuals With Hypertension ― Findings From a National Health and Nutrition Examination Study 1999–2018 ―

Associations between estimated and measured carotid-femoral pulse wave velocity in older Black and White adults: the atherosclerosis risk in communities (ARIC) study

Estimated pulse wave velocity as a measure of vascular aging

Carotid-Femoral pulse wave velocity progression in hypertensive patients is associated with subsequent cardiovascular outcomes

The incremental predictive value of arterial stiffness over SCORE2 in the setting of primary cardiovascular prevention: a 6-year follow-up study

The incremetal predictive value of pulse wave velocity over score2 in the setting of primary cardiovascular prevention: a 6-year follow-up study

Association between estimated pulse wave velocity and all-cause death in patients with heart failure

Estimated pulse wave velocity added additional prognostic information in general population: Evidence from National Health and Nutrition Examination Survey (NHANES) 1999–2018

Estimated Pulse Wave Velocity is Associated with All-Cause Mortality and Cardiovascular Mortality among Adults with Diabetes

Superior predictive value of estimated pulse wave velocity for all-cause and cardiovascular disease mortality risk in U.S. general adults

Different Methods for Measurements and Estimation of Pulse Wave Velocity are not Interchangeable

Estimated pulse wave velocity as a predictor of all-cause and cardiovascular mortality in patients with hypertension in China: a prospective cohort study

Estimated Pulse Wave Velocity and Cognitive Outcomes: A Post hoc Analysis of SPRINT-MIND

Prognostic significance of the estimated pulse wave velocity in critically ill patients with coronary heart disease: analysis from the MIMIC‑IV database

Estimated Pulse Wave Velocity is Associated with a Higher Risk of Dementia in the Health and Retirement Study

Estimated versus measured aortic stiffness: implications of diabetes, chronic kidney disease, sex and height

Clinical Validation of Carotid-Femoral Pulse Wave Velocity Measurement Using a Multi-Beam Laser Vibrometer: The CARDIS Study

Derivation of an Outcome-Driven Threshold for Aortic Pulse Wave Velocity: An Individual-Participant Meta-Analysis

Development of a comprehensive risk prediction model for arterial stiffness assessment in individuals with obesity